Not a good buy right now: momentum is bearish (MACD negative and worsening) and price is sitting just above near-term support.
No Intellectia edge today: neither AI Stock Picker nor SwingMax is giving a buy setup, so there’s no strong “must-buy-now” trigger for an impatient entry.
Fundamentals are trending the wrong way (2025/Q3 sharp YoY declines), and the next earnings (2026-02-24) is a near-term catalyst that could add downside volatility.
Options positioning looks call-skewed, but liquidity/volume is extremely thin today—sentiment signal is not reliable enough to override weak technicals/fundamentals.
Trend/Momentum: MACD histogram at -0.17 and negatively expanding = bearish momentum strengthening.
RSI: RSI(6) ~35.2 = weak/near-oversold territory, but not a confirmed reversal signal by itself.
Moving averages: converging MAs = indecision, but with MACD bearish, odds favor downside continuation unless support holds.
Key levels (pre-market ~17.98):
Support: S1 17.969 (price is essentially testing this), then S2 17.605.
Resistance: Pivot 18.559 (must reclaim to improve structure), then R1 19.15.
Pattern-based forward odds (provided): slight negative bias (next day -0.99% probability edge; next month -2.85%).
Options Data
Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio
Positioning: Open interest is call-heavy (call OI 2042 vs put OI 400; OI put/call 0.2) = bullish/hedge-light skew.
Activity: Today’s option volume is tiny (total volume 5; puts 0) despite “vs avg” spikes—so sentiment read is fragile.
Volatility: IV 30D ~81.28 with IV percentile 86.4 = options are priced for large moves; directional buys via options are expensive.
Takeaway: call-skew exists, but thin volume + very high IV makes this more of a “priced-in volatility” setup than a clean bullish signal.
Technical Summary
Sell
6
Buy
4
Positive Catalysts
holds and price reclaims the pivot (~18.
quickly.
Neutral/Negative Catalysts
= event risk with downside potential.
Financial Performance
Latest reported quarter: 2025/Q3.
Revenue: $211.21M, down -34.33% YoY (material contraction).
Net income: $19.892M, down -61.95% YoY.
EPS: 1.74, down -62.50% YoY.
Gross margin: 31.96%, down -5.47% YoY.
Bottom line: clear YoY deterioration across growth and profitability metrics—does not support an aggressive buy-right-now stance.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
No analyst rating trend or price target changes were provided in the dataset, so a current “Wall Street pros/cons” view cannot be validated here.
Trading flows to note instead: Hedge funds neutral (no significant last-quarter trend) and insiders neutral (no significant last-month trend).
Influential/political trading: No recent congress trading data available in the last 90 days.
Wall Street analysts forecast JAKK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JAKK is 27 USD with a low forecast of 27 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast JAKK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for JAKK is 27 USD with a low forecast of 27 USD and a high forecast of 27 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
